Sign up to view this video Join Now Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Optimizing CRO and Vendor Selection - Examples from the Field Decentralized by Design: Operationalizing Hybrid Rare Disease Trials
Sign up to view this video Join Now Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Optimizing CRO and Vendor Selection - Examples from the Field Decentralized by Design: Operationalizing Hybrid Rare Disease Trials
